AT306228B - Verfahren zur Herstellung pharmazeutischer Zubereitungen - Google Patents

Verfahren zur Herstellung pharmazeutischer Zubereitungen

Info

Publication number
AT306228B
AT306228B AT674171A AT674171A AT306228B AT 306228 B AT306228 B AT 306228B AT 674171 A AT674171 A AT 674171A AT 674171 A AT674171 A AT 674171A AT 306228 B AT306228 B AT 306228B
Authority
AT
Austria
Prior art keywords
manufacture
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
AT674171A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of AT306228B publication Critical patent/AT306228B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT674171A 1971-05-28 1971-08-02 Verfahren zur Herstellung pharmazeutischer Zubereitungen AT306228B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712126533 DE2126533A1 (de) 1971-05-28 1971-05-28 Verfahren zur Herstellung pharma zeutischer Zubereitungen

Publications (1)

Publication Number Publication Date
AT306228B true AT306228B (de) 1973-03-26

Family

ID=5809169

Family Applications (1)

Application Number Title Priority Date Filing Date
AT674171A AT306228B (de) 1971-05-28 1971-08-02 Verfahren zur Herstellung pharmazeutischer Zubereitungen

Country Status (13)

Country Link
US (1) US3917832A (de)
AT (1) AT306228B (de)
AU (1) AU3450471A (de)
BE (1) BE773121A (de)
BR (1) BR7105898D0 (de)
DE (1) DE2126533A1 (de)
ES (1) ES394319A1 (de)
FR (1) FR2139787B1 (de)
GB (1) GB1296510A (de)
HU (1) HU162454B (de)
IL (1) IL37640A (de)
NL (1) NL7111198A (de)
ZA (1) ZA715734B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401891D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
WO2004041208A2 (en) * 2002-11-05 2004-05-21 New River Pharmaceuticals Inc. Controlled absorption of mixed thyroyd hormone formulations
AU2008240374A1 (en) * 2007-04-23 2008-10-30 Diurnal Limited Sustained release
US9968574B2 (en) * 2009-05-15 2018-05-15 The University Of Kentucky Research Foundation Treatment of MCI and Alzheimer's disease
MX2011012015A (es) * 2009-05-15 2012-04-30 Univ Kentucky Res Found Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer.
WO2011142778A1 (en) * 2010-05-13 2011-11-17 The University Of Kentucky Research Foundation Treatment of mci and alzheimer's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2925364A (en) * 1957-08-12 1960-02-16 Baxter Laboratories Inc Method of treating hypercholesterol-emia with d-thyroxine
US3157574A (en) * 1959-05-01 1964-11-17 Smith Kline French Lab Method of reducing cholesterol levels

Also Published As

Publication number Publication date
ZA715734B (en) 1973-04-25
GB1296510A (de) 1972-11-15
IL37640A (en) 1974-10-22
BE773121A (fr) 1972-03-27
ES394319A1 (es) 1975-04-01
FR2139787A1 (de) 1973-01-12
BR7105898D0 (pt) 1973-05-10
US3917832A (en) 1975-11-04
NL7111198A (de) 1972-11-30
DE2126533A1 (de) 1972-12-14
HU162454B (de) 1973-02-28
IL37640A0 (en) 1971-12-29
FR2139787B1 (de) 1974-09-06
AU3450471A (en) 1973-04-19

Similar Documents

Publication Publication Date Title
AT287205B (de) Verfahren zur Herstellung von Arzneimittelzubereitungen
AT325201B (de) Verfahren zur herstellung von 7-acylamidocephalosporamsäuren
AT319259B (de) Verfahren zur Herstellung neuer Dihydropyridazone
AT306228B (de) Verfahren zur Herstellung pharmazeutischer Zubereitungen
AT327190B (de) Verfahren zur herstellung von 1-hydroxi-2-pyridonen
AT318920B (de) Verfahren zur Herstellung stabiler Zubereitungen
AT315829B (de) Verfahren zur Herstellung von 4-Halogenmethylcumarinen
AT312803B (de) Verfahren zur Herstellung von 7-Amino-desacetoxy-cephalosporansäure
AT327373B (de) Verfahren zur herstellung pharmazeutischer zubereitungen
AT309679B (de) Verfahren zur Herstellung von 6-Desoxytetracyclinen
ATA1092972A (de) Verfahren zur herstellung von 7-acylamino-3-substituierten-3-cephem-4-carbonsaurederivate
AT324553B (de) Verfahren zur herstellung von 3-alkylthiomethylcephalosporinen
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT327910B (de) Verfahren zur herstellung von 5-acyl-iminostilben-derivaten
DD101403A5 (de) Verfahren zur herstellung von phenylimidazolidinonen
AT326816B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
AT318823B (de) Verfahren zur Herstellung von 16-Carboxy-17-methoxy-eburnan
AT297216B (de) Verfahren zur Herstellung von therapeutischen Zubereitungen
AT336009B (de) Verfahren zur herstellung von 2-amino-2-oxazolinen
AT288596B (de) Verfahren zur Herstellung pharmazeutischer Präparate
AT315191B (de) Verfahren zur Herstellung von Arylsulfonylharnstoffen
CH528533A (de) Verfahren zur Herstellung von Thiazylharnstoffen
AT331240B (de) Verfahren zur herstellung von 4-chlor-2-hydroxybenzothiazol
AT314529B (de) Verfahren zur Herstellung von 1-Alkenyl-2-aminomethyl-pyrrolidinen
CH530405A (de) Verfahren zur Herstellung von 7-Chlor-benzodiazepin-Derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee